2170 Results

People

  1. Busam
    Busam
  2. Marghoob
    Marghoob
  3. Halpern
    Halpern
  4. Houghton
    Houghton
  5. Coit
    Coit
  6. Wolchok
    Wolchok
  7. Old
    Old
  8. Chapman
    Chapman
  9. Postow
    Postow
  10. Dusza
    Dusza

Groups

  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)
  7. Dermatology (393)
  8. Dermatology Service (387)
  9. Melanoma and Immunotherapeutics Service (380)
  10. Population Sciences Research Program (361)
  1. "melanoma"
Formats
  1. Journal Article (1939)
  2. Review (86)
  3. Editorial (32)
  4. Research Letter (28)
  5. Book Section (27)
  6. Conference Paper (19)
  7. Meeting Abstract (12)
  8. Guidelines (11)
  9. Miscellaneous (9)
  10. Correspondence (7)
Groups
  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)

More Groups

People
  1. Klaus Busam (217)
  2. Ashfaq Marghoob (212)
  3. Jedd Wolchok (180)
  4. Allan Halpern (153)
  5. Alan Houghton (138)
  6. Paul Chapman (125)

More People

Years
  1. 2025 (48)
  2. 2024 (94)
  3. 2023 (92)
  4. 2022 (94)
  5. 2021 (63)
  6. 2020 (76)

More Years

Publications
  1. Journal of the American Academy of Dermatology (89)
  2. Annals of Surgical Oncology (65)
  3. Journal of Clinical Oncology (65)
  4. Clinical Cancer Research (56)
  5. Cancer Research (48)
  6. Cancer (45)

More Publications

Publishers
  1. Elsevier Inc. (206)
  2. Springer (184)
  3. Wiley Blackwell (173)
  4. Lippincott Williams & Wilkins (166)
  5. American Association for Cancer Research (141)
  6. Mosby Elsevier (95)

More Publishers

Results (2170)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metformin is associated with improved clinical outcomes in patients with melanoma: A retrospective, multi-institutional study
    Journal Article

    Augustin, R. C.; Huang, Z.; Ding, F.; Zhai, S.; McArdle, J.; Santisi, A.; Davis, M.; Sander, C.; Davar, D.; Kirkwood, J. M.; more...
    Frontiers in Oncology (2023)

    Fulltext@MSK | Save
  • The family lifestyles, actions and risk education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors
    Journal Article

    Wu, Y. P.; Stump, T. K.; Hay, J. L.; Aspinwall, L. G.; Boucher, K. M.; Deboeck, P. R.; Grossman, D.; Mooney, K.; Leachman, S. A.; Smith, K. R.; more...
    Contemporary Clinical Trials (2023)

    Fulltext@MSK | Save
  • CD16(+) macrophages: An emerging biomarker for combined CTLA-4 and PD-1 blockade
    Editorial

    Smithy, J. W.; Luke, J. J.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
    Journal Article

    Ho, P.; Melms, J. C.; Rogava, M.; Frangieh, C. J.; Poźniak, J.; Shah, S. B.; Walsh, Z.; Kyrysyuk, O.; Amin, A. D.; Caprio, L.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • PRAME immunohistochemical expression and TERT promoter mutational analysis as ancillary diagnostic tools for differentiating proliferative nodules from melanoma arising in congenital nevi
    Journal Article

    Boutko, A.; Hagstrom, M.; Lampley, N.; Roth, A.; Olivares, S.; Dhillon, S.; Fumero-Velázquez, M.; Benton, S.; Zhao, J.; Zhang, B.; more...
    American Journal of Dermatopathology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Lipid droplets are a metabolic vulnerability in melanoma
    Journal Article

    Lumaquin-Yin, D.; Montal, E.; Johns, E.; Baggiolini, A.; Huang, T. H.; Ma, Y.; LaPlante, C.; Suresh, S.; Studer, L.; White, R. M.
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: A phase 1 study
    Journal Article

    Hamid, O.; Hassel, J. C.; Shoushtari, A. N.; Meier, F.; Bauer, T. M.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P. C.; Mauch, C.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Validation of the prognostic usefulness of the gene expression profiling test in patients with uveal melanoma
    Journal Article

    Miguez, S.; Lee, R. Y.; Chan, A. X.; Demkowicz, P. C.; Jones, B. S. C. L.; Long, C. P.; Abramson, D. H.; Bosenberg, M.; Sznol, M.; Kluger, H.; more...
    Ophthalmology (2023)

    Fulltext@MSK | Save
  • Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
    Journal Article

    Nabbi, A.; Danesh, A.; Espin-Garcia, O.; Pedersen, S.; Wellum, J.; Fu, L. H.; Paulson, J. N.; Geoerger, B.; Marshall, L. V.; Trippett, T.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save